Powder: -20°C for 3 years
In solvent: -80°C for 2 years
BMY-25271 is an antagonist of histamine H2 receptor.
Description | BMY-25271 is an antagonist of histamine H2 receptor. |
In vivo | The dose-response curves are parallel and oral ED50 values derived from probit analysis are 0.093, 0.97, and 6.9 mg/kg for BMY-25271, ranitidine, and cimetidine, respectively. BMY-25271 is about 10 and 74 times more potent than ranitidine and cimetidine, respectively. |
Molecular Weight | 329.44 |
Formula | C12H19N5O2S2 |
CAS No. | 78441-82-4 |
Powder: -20°C for 3 years
In solvent: -80°C for 2 years
( < 1 mg/ml refers to the product slightly soluble or insoluble )
You can also refer to dose conversion for different animals. More
bottom
Please see Inhibitor Handling Instructions for more frequently ask questions. Topics include: how to prepare stock solutions, how to store products, and cautions on cell-based assays & animal experiments, etc.
BMY-25271 78441-82-4 GPCR/G Protein Immunology/Inflammation Neuroscience Histamine Receptor BMY25271 BMY 25271 Inhibitor inhibitor inhibit